NEDD4L knockdown reduced lipid accumulation in non-alcoholic fatty liver disease by promoting the activity of PI3K/AKT signaling pathway Authors: Ju Zhou, Wu Li, Xiaowei Chi, Dingchun Li, Chunxia Yang, Zhiwen Duan Published: 2025 ABSTRACT BackgroundNon-alcoholic fatty liver disease (NAFLD) represents a prevalent liver disease that influences the physical health of patients. Nonetheless, the exact pathogenesis of NAFLD remains unclear.ObjectTo clarify how the neural precursor cell expressed developmentally downregulated 4-like (NEDD4L) regulates the lipid accumulation in the pathogenesis of NAFLD.MethodsNAFLD mouse models received a high-fat diet (60% fat). NAFLD primary hepatocyte models were established by treating hepatocytes with oleate (OA). NEDD4L knockdown mice were purchased and fed a diet containing 60% fat. NEDD4L was silenced in primary hepatocytes by transfection. Liver tissues were stained via hematoxylin and eosin (HE). Primary hepatocytes and liver tissues were stained via Oil Red O. Triglyceride (TG) levels in liver tissues and primary hepatocytes were detected via enzyme-linked immunosorbent assay (ELISA). Protein expression was determined via Western blot (WB).ResultsNEDD4L expression was elevated in liver tissues of NAFLD mice (P < 0.01). In addition, NEDD4L knockdown led to a reduction in body weight, liver weight, lipid accumulation, and TG levels in the liver tissues of NAFLD mice (P < 0.01). In NAFLD primary hepatocytes, NEDD4L knockdown led to a reduction in lipid accumulation and TG levels (P < 0.01). In summary, NEDD4L knockdown promoted the PI3K/AKT signaling pathway activity and decreased inflammatory factor levels in both NAFLD mice and primary hepatocyte models (P < 0.01).ConclusionNEDD4L knockdown increased the PI3K/AKT signaling pathway activity, leading to decreased lipid accumulation in NAFLD. Therefore, NEDD4L appears to be a useful target for NAFLD diagnosis and management.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40001-025-03620-1. Background Since its identification in the 1980s [1], non-alcoholic fatty liver disease (NAFLD) has emerged as the most widespread chronic liver condition globally, impacting nearly 30% of adults [2]. The likelihood of developing NAFLD is elevated in the presence of metabolic disorders, such as obesity and type 2 diabetes mellitus (T2DM) [3]. As these health issues continue to escalate, it is projected that the global prevalence of NAFLD will reach 55% by 2040[2]. Excessive deposition of lipids in the liver is one of the most important features of NAFLD, which leads to impaired liver function [4]. Without effective treatment, NAFLD can progress to cirrhosis [5]. While various ongoing studies have identified several genetic/metabolic abnormalities responsible for the pathogenesis of NAFLD, the underlying mechanisms of disease initiation and progression remain unclear, making early laboratory diagnosis and effective treatment challenging [6–8]. Neural precursor cell expressed developmentally downregulated 4-like (NEDD4L), commonly referred to as NEDD4-2, is located on human chromosome 18q21. It is a key member of the NEDD4 family and is a homolog of the mouse NEDD4-2 gene [9]. The expression of NEDD4L was found low in many human tumors, which facilitated the progression of these tumors, including colorectal cancer (CRC), gastric cancer, and non-small cell lung cancer (NSCLC) [10–12]. Recent studies have indicated that NEDD4L expression was dysregulated in liver-related diseases. For instance, the expression of NEDD4L protein in kidney tissues of liver cirrhosis rats induced by bile duct ligation was reduced by > 50% after the model was established for 2–4 weeks [13]. Zhao et al. [9] illustrated a downregulation of NEDD4L in hepatocellular carcinoma tissues. Furthermore, hepatocellular carcinoma patients with low NEDD4L expression demonstrated a poor prognosis. Concurrently, NEDD4L knockdown has been shown to stimulate the proliferation of hepatocellular carcinoma cells in vitro. Fu et al. [14] revealed that glucagon signaling was crucial for glucose output during fasting. Notably, NEDD4L protein levels increased in liver tissues of fasted mice and in primary mouse hepatocytes treated with glucagon. However, detailed data about the impact of NEDD4L on NAFLD are not yet available. In this study, an analysis of datasets from Gene Expression Omnibus (GEO) illustrated an upregulation of NEDD4L expression in mice fed a medium-fat diet and in Sk-hep1 cells cultured with high-fat medium, and it was verified through in vitro and in vivo experiments. The PI3K/AKT signaling pathway, which has been discovered as a contributor to the development of NAFLD [15], was also confirmed to be regulated by NEDD4L in the current study. The findings of this study have the potential to provide a useful target for NAFLD diagnosis and treatment. Methods Analysis of data from GEO database NEDD4L expression levels in Sk-hep1 cells cultured in a high-fat medium (n = 6) or growth medium (n = 6) were retrieved from the GEO database for further analysis (GSE109836). Meanwhile, based on data from the GEO database (GSE53188), NEDD4L expression levels in C57BL/6 J mice that were fed a medium-fat diet (n = 4) or subjected to calorie restriction (n = 4) or fed a normal fat diet (control n = 4) were analyzed. Animals and treatment C57BL/6 J mice (n = 10, aged 5–6 weeks) were sourced from the Shanghai Experimental Animal Center, Chinese Academy of Sciences (Shanghai, China). C57BL/6 J mice transfected by NEDD4L shRNA (n = 5) or a negative control (n = 5) were purchased from the University of Science and Technology (Wuhan, China). The ethics committee has approved the use of animals in the current study. Ten C57BL/6 J mice were randomized into the high-fat diet (HFD) (n = 5) and normal chow diet (NCD) groups (n = 5). A high-fat diet containing 60% fat was given to mice in the HFD group (D12492; Research Diets Inc., New Brunswick, New Jersey, USA). A normal chow diet containing 10% fat was given to mice in the NCD group (D12450B; Research Diets Inc.). C57BL/6 J mice transfected by NEDD4L shRNA or a negative control received a high-fat diet (60% fat) (grouped as HFD + shNEDD4L group or HFD + shNC group). In a 12-h day/night cycle room at (22 ± 2) °C, all mice were fed for 15 weeks and had unrestricted access to water [5]. After 15 weeks, they were weighed and euthanized to collect liver tissues which were then weighed and stored at − 80 °C. Hematoxylin and eosin (HE) staining Liver tissues were fixed in 10% formalin at 4 °C for an entire night, embedded in paraffin, and sectioned at 5 μm. Utilizing a thermostat at 45 °C, sections were dried and then dewaxed via Xylene for 10 min. Gradient alcohol was used to rehydrate these sections. HE staining solutions were used for 5-min staining. The gradient alcohol was employed to dehydrate sections, followed by 1-min treatment with xylene. The neutral resin was employed for sealing sections after air drying at room temperature and examined under a microscope. Cell culture and transfection Primary hepatocytes were sourced from the American Type Culture Collection (ATCC, Rockville, MD, USA) and incubated in a 5% CO2 environment at 37 °C in Dulbecco’s modified Eagle’s medium (DMEM) containing 100 μg/mL streptomycin, 100 U/mL penicillin, and 10% fetal bovine serum (FBS). The primary hepatocytes were collected and dispersed into serum-free DMEM at about 80% confluence. The resulting single-cell suspension had a concentration of 1 × 106 cells/mL. Next, the suspension was inoculated into 6-well plates at 1 mL/well. These hepatocytes were then transfected with NEDD4L shRNA or a negative control (Genechem, Shanghai, China) via Lipofectamine 3000 (Thermo Fisher Scientific, Waltham, MA, USA) based on the instructions. Following an 8-h culture at 37 °C with 5% CO2, the hepatocytes were incubated in DMEM containing 10% FBS. Cell treatment NAFLD cell model was established by treating primary hepatocytes with Oleate (OA). Briefly, OA was added into DMEM (with 10% FBS) to a concentration of 0.5 mM. Primary hepatocytes were inoculated at 1 × 106 cells into 6-well plates and cultured with 0.5 mM OA and 1 mL of DMEM containing 10% FBS (set as OA group). Primary hepatocytes transfected by NEDD4L shRNA or a negative control were also cultured with 0.5 mM OA and 1 mL of DMEM containing 10% FBS in 6-well plates (OA + shNEDD4L group or OA + shNC group). The control group was set up with primary hepatocytes in DMEM containing 10% FBS. Primary hepatocytes of each group were incubated at 37 °C for 48 h in a 5% CO2 environment. Oil Red O staining Primary hepatocytes and liver tissues were evaluated via Oil Red O staining for the formation of lipid droplets [16]. Liver tissue sections (a thickness of 5 μm) were treated with xylene and gradient alcohol for hydration. Phosphate buffered saline (PBS) was adopted for washing these sections. After adding the Oil Red O reagent, the sections were subjected to a 30-min culture and then treated with haematoxylin for 1 min. Primary hepatocytes were cultured for 48 h in 6-well plates pre-coating with cover glass. PBS was then used to wash the cells. After a 5-min fixation in 10% formalin, the primary hepatocytes were stained for 30 min via Oil Red O reagent. Distilled water was used to wash the primary hepatocytes. Then, haematoxylin was added to stain them for 1 min. Liver tissue sections and primary hepatocytes were examined under a microscope following dehydration. Enzyme-linked immunosorbent assay (ELISA) TG levels in liver tissues and primary hepatocytes were determined via ELISA kits (Beyotime, Shanghai, China) based on the instructions. In brief, liver tissues were homogenized, followed by lysis in a 5% NP-40/ddH2O solution. Primary hepatocytes were collected after 48 h of culture, followed by treatment with cell lysates. The cell lysate and liver tissue homogenate were then centrifuged for 10 min at 4 °C and 12000 × g. TG levels were detected via the harvested supernatant. Western blot (WB) Total proteins in primary hepatocytes and liver tissues were extracted via RIPA lysis buffer containing protease inhibitors (Solarbio, Beijing, China). For determining the concentration of total protein, a BCA kit (Beyotime, Shanghai, China) was employed. For the sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 30 μg of protein samples were transferred onto a polyvinylidene fluoride (PVDF) membrane. 5% skimmed milk was applied to the membrane for 30 min. After that, a 12-h probing of the membrane was performed at 4 °C via primary antibodies. The following is a list of rabbit anti-primary antibodies: anti-NEDD4L (1:1000, BY-3506R, Kaibo Biological Technology, Shanghai, China), anti-TNF-α (1:1000, ab9635, Abcam, Cambridge, MA, USA), anti-IL-1β (1:1000, ab9722, Abcam, Cambridge, MA, USA), anti-IL6 (1:1000, ab6672, Abcam, Cambridge, MA, USA), anti-p-p65 (1:500, ab86299, Abcam, Cambridge, MA, USA), anti-p65 (1:1000, ab16502, Abcam, Cambridge, MA, USA), anti-p-PI3K (1:500, BY-3332R, Kaibo Biological Technology, Shanghai, China), anti-PI3K (1:1000, 17-3624 M, Kanglang, Shanghai, China), anti-p-AKT (1:500, HK13865, Husbio, Shanghai, China), anti-AKT (1:1000, ab8805, Abcam, Cambridge, MA, USA), and anti-β-actin (1:1000, ab8226, Abcam, Cambridge, MA, USA). Thereafter, the membrane was treated at room temperature for 2 h via a secondary antibody (ab205718, Abcam, Cambridge, MA, USA) conjugated with horseradish peroxidase (HRP). The enhanced chemiluminescence (ECL) reagent was utilized based on the instructions for visualizing protein blots. Utilizing Image J software (National Institutes of Health, Bethesda, Maryland, USA), the gray density was determined for each protein blot. β-actin served as the internal control when calculating the relative protein expression. Statistical analysis Each experiment was repeated 3 times separately. For data analysis, GraphPad Prism 6.0 was employed. The information was displayed as mean ± standard deviation (SD). A two-tailed paired Student’s t-test was adopted for two-group comparisons. Tukey’s post hoc test was applied for multiple comparisons after a one-way analysis of variance (ANOVA). P < 0.05 was defined as statistically significant. Results Elevated NEDD4L expression in liver tissues of NAFLD mice Analysis of data from the GEO database exhibited that Sk-hep1 cells incubated in the high-fat medium had much higher NEDD4L expression than those incubated in the growth medium (Fig. 1A). C57BL/6 J mice that received medium fat exhibited obviously higher NEDD4L expression than those fed with normal fat (control). Compared with the mice fed a medium-fat diet, those subjected to calorie restriction presented much lower NEDD4L expression (Fig. 1B). NEDD4L protein expression in liver tissues was determined via WB. The result is shown in Fig. 1C. Compared with mice in NCD group, those in HFD group had much higher NEDD4L protein expression in liver tissues (P < 0.01).Fig. 1NEDD4L expression was increased in liver tissues of NAFLD mice. A According to data from GEO database (GSE109836), Sk-hep1 cells cultured in high-fat medium had much higher NEDD4L expression. B According to data from GEO database (GSE53188), mice fed a medium-fat diet had much higher NEDD4L expression. C WB indicated that NAFLD mice exhibited much higher NEDD4L protein expression in liver tissues. ** P < 0.01 NEDD4L expression was increased in liver tissues of NAFLD mice. A According to data from GEO database (GSE109836), Sk-hep1 cells cultured in high-fat medium had much higher NEDD4L expression. B According to data from GEO database (GSE53188), mice fed a medium-fat diet had much higher NEDD4L expression. C WB indicated that NAFLD mice exhibited much higher NEDD4L protein expression in liver tissues. ** P < 0.01 Reduction of lipid accumulation in liver tissues of NAFLD mice by NEDD4L knockdown WB presented that compared to NCD group, HFD group demonstrated much higher NEDD4L protein expression (P < 0.01). NEDD4L protein expression was significantly lower in liver tissues in HFD + shNEDD4L group (P < 0.01) than in HFD + shNC group (Fig. 2A). The body weight and liver weight of mice in each group was measured. As a result, mice in NCD group exhibited markedly higher body weight and liver weight compared to those in HFD group (P < 0.01). Nonetheless, the liver weight and body weight were obviously lower in HFD + shNEDD4L group (P < 0.01) than in HFD + shNC group (Fig. 2B). When comparing the liver tissues from mice in HFD group and NCD group, more lipid droplets with larger sizes were revealed in HFD group via HE and Oil Red O staining. A comparison indicated that relative to HFD + shNC group, the size and quantity of lipid droplets in mice’s liver tissues in the HFD + shNEDD4L group were noticeably lower (Fig. 2C, D). TG level in liver tissues was detected. The results indicated that HFD group presented a much higher liver TG level than NCD group (P < 0.01). Oppositely, compared to HFD + shNC group, HFD + shNEDD4L group showed obviously lower liver TG level (P < 0.01) (Fig. 2E).Fig. 2NEDD4L knockdown reduced lipid accumulation in liver tissues of NAFLD mice. A NEDD4L protein expression was reduced in liver tissues of NEDD4L knockdown mice. B NEDD4L knockdown decreased the body weight and liver weight of NAFLD mice. C and D HE staining and Oil Red O staining revealed that NEDD4L knockdown reduced lipid droplets in liver tissues of NAFLD mice. E NEDD4L knockdown reduced liver TG level of NAFLD mice. ** P < 0.01 compared with NCD group. ## P < 0.01 compared with HFD + shNC group NEDD4L knockdown reduced lipid accumulation in liver tissues of NAFLD mice. A NEDD4L protein expression was reduced in liver tissues of NEDD4L knockdown mice. B NEDD4L knockdown decreased the body weight and liver weight of NAFLD mice. C and D HE staining and Oil Red O staining revealed that NEDD4L knockdown reduced lipid droplets in liver tissues of NAFLD mice. E NEDD4L knockdown reduced liver TG level of NAFLD mice. ** P < 0.01 compared with NCD group. ## P < 0.01 compared with HFD + shNC group Reduction of TG level in liver cells by NEDD4L knockdown The OA group presented markedly higher NEDD4L protein expression than the control group with regard to primary hepatocytes (P < 0.01). To the contrary, compared to OA + shNC group, OA + shNEDD4L group showed significantly lower NEDD4L protein expression in primary hepatocytes (P < 0.01) (Fig. 3A). Oil Red O staining revealed that relative to the control group, OA group exhibited more lipid droplets with larger sizes in primary hepatocytes. Compared to the OA + shNC group, the size and quantity of lipid droplets in the OA + shNEDD4L group declined in primary hepatocytes (Fig. 3B). In addition, the OA group exhibited much higher TG levels than the control group in primary hepatocytes (P < 0.01). Oppositely, compared to OA + shNC group, the TG level was much reduced in primary hepatocytes of OA + shNEDD4L group (P < 0.01) (Fig. 3C).Fig. 3NEDD4L knockdown reduced TG level in hepatocytes. A NEDD4L knockdown reduced NEDD4L expression in primary hepatocytes treated by OA. B NEDD4L knockdown decreased lipid droplets in primary hepatocytes treated by OA. C NEDD4L knockdown declined TG level in primary hepatocytes treated by OA. ** P < 0.01 compared with the control group. ## P < 0.01 compared with OA + shNC group NEDD4L knockdown reduced TG level in hepatocytes. A NEDD4L knockdown reduced NEDD4L expression in primary hepatocytes treated by OA. B NEDD4L knockdown decreased lipid droplets in primary hepatocytes treated by OA. C NEDD4L knockdown declined TG level in primary hepatocytes treated by OA. ** P < 0.01 compared with the control group. ## P < 0.01 compared with OA + shNC group Reduction of inflammatory factor level in NAFLD tissues and cells by NEDD4L knockdown WB presented that compared to NCD group, HFD group demonstrated markedly higher expression of p-p65/p65, IL-1β, and TNF-α proteins in liver tissues (P < 0.01). However, relative to HFD + shNC group, HFD + shNEDD4L group showed remarkably lower expression of p-p65/p65, IL-1β, and TNF-α proteins in liver tissues of mice (P < 0.01) (Fig. 4A). Additionally, relative to the control group, primary hepatocytes of OA group exhibited obviously higher expression of p-p65/p65, IL6, IL-1β, and TNF-α proteins (P < 0.01). On the contrary, relative to OA + shNC group, OA + shNEDD4L group exhibited dramatically lower expression of p-p65/p65, IL6, IL-1β, and TNF-α proteins in primary hepatocytes (P < 0.01) (Fig. 4B).Fig. 4NEDD4L knockdown reduced inflammatory factor levels in NAFLD tissues and cells. A WB revealed that NEDD4L knockdown reduced the expression of TNF-α, IL-1β, and p-p65/p65 proteins in liver tissues of NAFLD mice. B NEDD4L knockdown reduced the expression of TNF-α, IL-1β, IL6 and p-p65/p65 proteins in primary hepatocytes treated by OA. ** P < 0.01 relative to NCD group or the control group. ## P < 0.01 relative to HFD + shNC group or OA + shNC group NEDD4L knockdown reduced inflammatory factor levels in NAFLD tissues and cells. A WB revealed that NEDD4L knockdown reduced the expression of TNF-α, IL-1β, and p-p65/p65 proteins in liver tissues of NAFLD mice. B NEDD4L knockdown reduced the expression of TNF-α, IL-1β, IL6 and p-p65/p65 proteins in primary hepatocytes treated by OA. ** P < 0.01 relative to NCD group or the control group. ## P < 0.01 relative to HFD + shNC group or OA + shNC group Promotion of the PI3K/AKT signaling pathway activity in NAFLD tissues and cells by NEDD4L knockdown For NAFLD tissues and cells, WB was employed to examine the phosphorylation of PI3K and AKT. A comparison of liver tissues of mice between HFD group and NCD group revealed significantly lower ratios of p-PI3K/PI3K and p-AKT/AKT (P < 0.01). Regarding p-PI3K/PI3K and p-AKT/AKT ratios in liver tissues of mice, it was noticeably higher in HFD + shNEDD4L group (P < 0.01) than in HFD + shNC group (Fig. 5A). Furthermore, the OA group exhibited markedly lower p-PI3K/PI3K and p-AKT/AKT ratios than the control group in primary hepatocytes (P < 0.01). In contrast, p-PI3K/PI3K and p-AKT/AKT ratios were much higher in OA + shNEDD4L group (P < 0.01) than in OA + shNC group (Fig. 5B).Fig. 5NEDD4L knockdown promoted the PI3K/AKT signaling pathway activity in NAFLD tissues and cells. A NEDD4L knockdown increased the phosphorylation of PI3K/AKT in liver tissues of NAFLD mice. B NEDD4L knockdown elevated the phosphorylation of PI3K/AKT in primary hepatocytes treated by OA. ** P < 0.01 relative to NCD group or the control group. ## P < 0.01 relative to HFD + shNC group or OA + shNC group NEDD4L knockdown promoted the PI3K/AKT signaling pathway activity in NAFLD tissues and cells. A NEDD4L knockdown increased the phosphorylation of PI3K/AKT in liver tissues of NAFLD mice. B NEDD4L knockdown elevated the phosphorylation of PI3K/AKT in primary hepatocytes treated by OA. ** P < 0.01 relative to NCD group or the control group. ## P < 0.01 relative to HFD + shNC group or OA + shNC group Discussion It has been reported that approximately 25% of the adult population suffers from NAFLD globally. Even worse, the incidence of NAFLD is up to 90% and about 76% in severely obese individuals and T2DM population respectively [17]. Lipid buildup is a well-known primary feature of NAFLD [18]. An essential function of the liver is to control lipid metabolism [19]. However, the accumulation of lipid droplets can lead to a progressive deterioration in the liver’s normal physiological functions, potentially resulting in systemic metabolic dysfunction [20, 21]. Fatty acid storage and transport in plasma and cells primarily occur via TG. Under normal circumstances, the liver only stores a limited amount of fatty acids, such as TG. However, the liver’s fatty acid metabolism is disturbed in the context of NAFLD, leading to TG accumulation in liver cells [22]. Excessive TG accumulation can result in several liver diseases, including inflammation, fibrosis, cirrhosis, and even cancer [23]. Consequently, reducing the accumulation of lipids, including TG, is a primary objective in the treatment of NAFLD. In this study, an NAFLD model was established using mice and primary hepatocytes. A higher expression of NEDD4L was found in NAFLD mice and cells models. Additionally, the NAFLD group exhibited significant TG accumulation. In comparison to the results from a previous study that demonstrated the activation of PI3K/AKT signaling pathway enhanced lipid metabolism and improved NAFLD [24], the current study hypothesized that NEDD4L could suppress lipid metabolism by downregulating PI3K/AKT pathway expression. Interestingly, it was found in the NAFLD mice model that the PI3K/AKT pathway was significantly downregulated in the HFD group and significantly upregulated in the HFD group in case of NEDD4L knockdown. This finding was consistent with the in vitro experiment, which further validated our hypothesis. Zhang et al. [25] illustrated that the block of PI3K reversed the beneficial effect of Silibinin on cellular steatosis in NAFLD rats. Yang et al. [26] discovered that NEDD4L overexpression reduced the p-AKT protein level in CRC cells. On the contrary, Wang et al. [27] indicated that NEDD4L expression inhibition resulted in the accumulation of PIK3CA (an oncogene), but led to an abnormal decrease in the activity of AKT. NEDD4L (also known as RSP5) was found to be highly expressed during the osteogenesis of mesenchymal stem cells. By triggering the AKT signaling pathway, it promoted mesenchymal stem cells to differentiate into osteoblasts [28]. Non-alcoholic steatohepatitis (NASH) is another common clinicopathological feature of NAFLD [29]. Severe steatohepatitis is more likely to develop into liver cirrhosis, and even hepatocellular carcinoma [16]. In this study, significant upregulation of inflammatory factors, including p-p65/p65, IL6, TNF-α, and IL-1β, was observed in NAFLD group, and significant downregulation of these factors was noticed in case of NEDD4L knockdown or silencing, suggesting that NEDD4L expression might play a role in regulating inflammatory responses and potentially contributing to the development of NASH in NAFLD patients. In conclusion, NEDD4L protein overexpression was identified in both NAFLD both mice and primary hepatocyte models. This overexpression can promote lipid accumulation by suppressing PI3K/AKT expression and regulate the inflammatory responses, thus inducing NASH in NAFLD patients. Consequently, NEDD4L emerges as a promising target for NAFLD treatment. Supplementary Information Supplementary Material 1. Supplementary Material 1.